Pfizer This fall Earnings: Income And EPS Beat, Seagen And COVID-19 Merchandise Present Energy, Points Robust FY25 Outlook – Pfizer (NYSE:PFE)
On Tuesday, Pfizer Inc. PFE reported fourth-quarter adjusted EPS of 63 cents, in comparison with 10 cents a 12 months in the past, beating the consensus of...
Amgen Impresses With This fall Earnings Beat, Analysts See Progress Forward – Amgen (NASDAQ:AMGN)
On Tuesday, Amgen Inc AMGN reported fourth-quarter gross sales of $9.10 billion, up 11% year-over-year, beating the consensus of $8.9 billion.
Product gross sales grew 11%,...
Novo Nordisk This fall Earnings: Wegovy Gross sales Extra Than Double, Seeks Regulatory Approval For Hybrid Weight Loss Drug In 2026 – Novo Nordisk...
On Wednesday, Novo Nordisk A/S NVO reported gross sales of roughly $12.25 billion (85.68 billion Danish kroner) for the fourth quarter of 2024, beating...
Hashish Takes On Superbugs: May This New Drug ‘Change An infection Remedy Ceaselessly’?
"We acquired actually fortunate about six years in the past after we began exploring how cannabinoids is likely to be used to deal with...
Novo Nordisk Inventory Slides Earlier than This fall Earnings: Analysts Nonetheless See 68% Upside – Novo Nordisk (NYSE:NVO)
Novo Nordisk A/S NVO will report its fourth-quarter earnings on Wednesday. Wall Road expects 86 cents in EPS and $11.40 billion in revenues as...